Updated Jul 16, 2026
McDermott Michael is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Michael McDermott is an Executive Vice President at Pfizer Inc., a leading global biopharmaceutical company. He has held various leadership roles within the organization, contributing to its strategic direction and operational excellence. McDermott has a strong background in the pharmaceutical industry and is recognized for his expertise in managing complex projects and driving innovation.
| Role | Executive Vice President |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-27 | PFE | PFIZER INC | F — Tax withholding / forfeiture | 3.5K | $27.10 | $95K |
| 2026-02-27 | PFE | PFIZER INC | F — Tax withholding / forfeiture | 36.0K | $26.92 | $970K |
| 2026-02-27 | PFE | PFIZER INC | F — Tax withholding / forfeiture | 679 | $27.09 | $18K |
| 2026-02-27 | PFE | PFIZER INC | M — Option exercise | 37.9K | $33.82 | $1.28M |
Michael McDermott is an Executive Vice President at Pfizer Inc., a leading global biopharmaceutical company. He has held various leadership roles within the organization, contributing to its strategic direction and operational excellence. McDermott has a strong background in the pharmaceutical industry and is recognized for his expertise in managing complex projects and driving…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McDermott Michael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.